πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7279458

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7265133

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7265086

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7262205

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256294

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250414

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244705

Polyacid glycopeptide derivatives

Theravance, Inc. Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7238709

Therapeutic carbamates

Theravance, Inc. Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226950

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226946

Substituted phenol compounds useful for anesthesia and sedation

Theravance, Inc. Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223783

Indolinone derivatives

Theravance, Inc. Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7217738

Ξ²2-adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208471

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208515

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7195876

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183323

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183292

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179794

Multivalent macrolide antibiotics

Theravance, Inc. Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173039

Protein kinase inhibitors

Theravance, Inc. Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7160984

Process for preparing glycopeptide derivatives

Theravance, Inc. Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157554

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. Β· Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7151115

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141671

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132422

Sodium channel modulators

Theravance, Inc. Β· Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted